The current valuation score of Septerna Inc is 6.52, ranking 287 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -42.61, which is -105.27% below the recent high of 2.24 and -9.84% above the recent low of -46.80.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.